US Market Report for Spinal Machined Bone Allograft 2017 - MedCore

  • ID: 4085816
  • Report
  • Region: United States
  • 467 pages
  • iData Research
1 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

General Report Contents

- Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends

- Market Drivers & Limiters for each chapter segment

- Competitive Analysis for each chapter segment

- Section on recent mergers & acquisitions

The 2016 spinal machined bone allograft market comprises anterior, posterior, transforminal and cervical interbody fusions. Anterior lumbar interbody fusion represented the largest segment. Closely following was CIF, PLIF and TLIF. The proportion of the machined bone allograft market by treatment will remain similar over the forecast period; the greatest change will be for the CIF segment, which will become the largest in the market by 2023.

All segments of this market will decline, experiencing both dropping unit sales and average selling prices. The PLIF and ALIF segments will be hit the hardest. Even though the number of spinal fusions performed in the United States is growing, this growth is associated with increased PEEK usage rather than machined bone allograft.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Anika Therapeutics
  • Bioventus
  • DePuy Synthes
  • Ferring Pharmaceuticals
  • Genzyme
  • Integra LifeSciences
  • MORE

Competitive Analysis
Market Trends
Market Developments
Procedure Numbers
Markets Included
Key Report Updates
Version History

1. Research Methodology
1.1 Research Scope
1.2 9-Step Methodology
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems And Perform Secondary Research
Step 3: Preparation For Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast And Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review And Market Release
Step 9: Customer Feedback And Market Monitoring

2. Disease Overview
2.1 Basic Anatomy
2.1.1 Osteology And Musculoskeletal System
2.2 Disease Pathology And Disorders
2.2.1 General Diagnostic
2.2.2 Osteoporosis
2.2.3 Osteoarthritis
2.2.4 Indication For Bone Graft Procedure
2.2.5 Indication For Cartilage Repair
2.2.6 Degenerative Disc Disease
2.3 Patient Demographics
2.3.1 General Statistics

3. Product Assessment
3.1 Product Portfolios
3.1.1 Spinal Machined Bone Allografts
3.2 Regulatory Issues And Recalls
3.2.1 Spinal Machined Bone Allografts
3.3 Clinical Trials
3.3.1 Spinal Machined Bone Allografts

4. Spinal Machined Bone Allograft Market
4.1 Introduction
4.1.1 Anterior Lumbar Interbody Fusion (Alif)
4.1.2 Posterior Lumbar Interbody Fusion (Plif)
4.1.3 Transforaminal Lumbar Interbody Fusion (Tlif)
4.1.3.1 Lateral Lumbar Interbody Fusion (Llif)
4.1.3.2 Cervical Interbody Fusion (Cif)
4.1.4 Machined Bone Material
4.2 Market Overview
4.3 Market Analysis And Forecast
4.3.1 Total Spinal Machined Bone Allograft Market
4.3.1.1 Alif Machined Bone Allograft Market
4.3.1.2 Plif Machined Bone Allograft Market
4.3.1.3 Tlif Machined Bone Allograft Market
4.3.1.4 Cif Machined Bone Allograft Market
4.4 Drivers And Limiters
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 Competitive Market Share Analysis

List of Charts

Chart 1 1: Orthopedic Biomaterials Market By Segment, U.S., 2013 - 2023
Chart 1 2: Orthopedic Biomaterials Market Overview, U.S., 2016 & 2023
Chart 4 1: Spinal Machined Bone Allograft Market By Segment, U.S., 2013 - 2023
Chart 4 2: Spinal Machined Bone Allograft Market Breakdown, U.S., 2016
Chart 4 3: Spinal Machined Bone Allograft Market Breakdown, U.S., 2023
Chart 4 4: Total Spinal Machined Bone Allograft Market, U.S., 2013 - 2023
Chart 4 5: Alif Machined Bone Allograft Market, U.S., 2013 - 2023
Chart 4 6: Plif Machined Bone Allograft Market, U.S., 2013 - 2023
Chart 4 7: Tlif Machined Bone Allograft Market, U.S., 2013 - 2023
Chart 4 8: Cif Machined Bone Allograft Market, U.S., 2013 - 2023
Chart 4 9: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016

List of Figures

Figure 1 1: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (1 Of 2)
Figure 1 2: Orthopedic Biomaterials Market Share Ranking By Segment, U.S., 2016 (2 Of 2)
Figure 1 3: Companies Researched In This Report, U.S., 2016
Figure 1 4: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (1 Of 2)
Figure 1 5: Factors Impacting The Orthopedic Biomaterials Market By Segment, U.S. (2 Of 2)
Figure 1 6: Recent Events In The Orthopedic Biomaterials Market, U.S., 2013 - 2016
Figure 1 7: Orthopedic Biomaterials Markets Covered, U.S., 2016 (1 Of 2)
Figure 1 8: Orthopedic Biomaterials Markets Covered, U.S., 2016 (2 Of 2)
Figure 1 9: Orthopedic Biomaterials Markets Covered, U.S., 2016(1 Of 3)
Figure 3 1: Spinal Machined Bone Allograft Products By Company
Figure 3 2: Class 2 Device Recall Stryker Radius Spinal System
Figure 3 3: Study Of Nucel For One And Two Level Lumbar Interbody Fusion
Figure 3 4: An Acdf Multi-Center Study Using Vivigen Cellular Bone Matrix
Figure 3 5: An Assessment Of P-15 Bone Putty In Anterior Cervical Fusion With Instrumentation
Figure 3 6: Interbody Spacers With Map3® Cellular Allogeneic Bone Graft In Anterior Or Lateral Lumbar Interbody Fusion
Figure 3 7: Efficacy Study Of Nucel® In Patients Undergoing Fusion Of The Lumbar Spine
Figure 3 8: Prospective Study Of Thoracolumbar Spinal Fusion Graft (Bmac)
Figure 3 9: Cellentra Viable Cell Bone Matrix (Vcbm) Anterior Cervical Discectomy And Fusion Outcomes Study (Vcbm/Maxan) (Vcbm/Acdf)
Figure 3 10: Prospective Study Of Thoracolumbar Spinal Fusion Graft (Bmac)
Figure 3 11: Peek And Allograft Spacers Evaluation In Spinal Fusion Surgeries (Peek)
Figure 3 12: Restore Clinical Trial
Figure 3 13: A Prospective Study Of Nucel® In Cervical Spine Fusion
Figure 3 14: Safety And Preliminary Efficacy Study Of Neofuse In Subjects Undergoing Multi-Level Anterior Cervical Discectomy
Figure 4 1: Spinal Machined Bone Allograft Market By Segment, U.S., 2013 - 2023 (Us$M)
Figure 4 2: Total Spinal Machined Bone Allograft Market, U.S., 2013 - 2023
Figure 4 3: Alif Machined Bone Allograft Market, U.S., 2013 - 2023
Figure 4 4: Plif Machined Bone Allograft Market, U.S., 2013 - 2023
Figure 4 5: Tlif Machined Bone Allograft Market, U.S., 2013 - 2023
Figure 4 6: Cif Machined Bone Allograft Market, U.S., 2013 - 2023
Figure 4 7: Drivers And Limiters, Spinal Machined Bone Allograft Market, U.S., 2016
Figure 4 8: Leading Competitors, Spinal Machined Bone Allograft Market, U.S., 2016
Figure 6 1: Press Release Summary

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Medtronic
  • Genzyme
  • DePuy Synthes
  • Anika Therapeutics
  • Ferring Pharmaceuticals
  • Stryker
  • NuVasive
  • Bioventus
  • Zimmer Biomet
  • Integra LifeSciences
  • RTI Surg
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll